Hydroxyzine Medical Valley

Hydroxyzine, the active ingredient in Hydroxyzine Medical Valley, is a first‑generation antihistamine presented as an oral dosage form for oral use. It treats allergic conditions such as rhinitis and urticaria, helps relieve anxiety and tension, and provides sedation before or after surgical procedures.

GNH USA supplies Hydroxyzine Medical Valley as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Hydroxyzine acts on histamine H1 receptors to alleviate symptoms of allergic and anxiety‑related conditions.

Allergic rhinitis: reduces nasal itching, sneezing and congestion. Urticaria (hives): diminishes wheal formation and itching. Anxiety and tension: provides calming effect and reduces nervousness. Sedation before/after surgery: induces pre‑operative calm and postoperative sleep. Nausea and vomiting: helps control postoperative and motion‑related nausea.

Hydroxyzine may cause a range of adverse reactions.

Common Side Effects: - Drowsiness or sedation - Dry mouth - Blurred vision - Constipation - Headache - Dizziness

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis) - Cardiac arrhythmias or QT prolongation - Seizures - Hepatic dysfunction - Blood dyscrasias (e.g., agranulocytosis) - Extrapyramidal symptoms

Hydroxyzine should be used with caution in specific situations.

Pregnancy: Category B – use only if potential benefit justifies the risk. Elderly: increased sensitivity to sedation and anticholinergic effects. Driving: avoid operating machinery until individual response is known. Alcohol: avoid concurrent consumption due to enhanced CNS depression. Drug interactions: review all concomitant medications for potential additive effects. Store at ambient temperature below 25°C: keep in original packaging, protect from moisture and light.

Hydroxyzine can interact with several drug classes.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of severe hypotension. - Central nervous system depressants (benzodiazepines, opioids): additive sedation. - Anticholinergic agents: heightened anticholinergic burden. - QT‑prolonging drugs: increased risk of cardiac arrhythmias. - Alcohol: potentiates sedative effects.

Moderate Interactions (Monitor Closely):\n- Antihypertensives: may enhance hypotensive response. - Other antihistamines: additive drowsiness. - CYP450 inhibitors or inducers: may alter hydroxyzine plasma levels. - Anticholinergic medications: monitor for excessive dry mouth and constipation.